S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
S&P 500   3,699.12 (+0.88%)
DOW   30,218.26 (+0.83%)
QQQ   305.52 (+0.41%)
AAPL   122.25 (-0.56%)
MSFT   214.36 (+0.06%)
FB   279.70 (-0.76%)
GOOGL   1,823.76 (+0.11%)
AMZN   3,162.58 (-0.76%)
TSLA   599.04 (+0.95%)
NVDA   542.33 (+1.21%)
BABA   267.25 (+0.13%)
CGC   28.59 (-0.14%)
GE   10.88 (+2.64%)
MU   73.34 (+4.92%)
AMD   94.04 (+1.87%)
T   29.54 (+1.06%)
NIO   43.04 (-5.09%)
F   9.34 (+1.41%)
ACB   10.89 (-3.11%)
BA   232.71 (-1.89%)
NFLX   498.31 (+0.16%)
GILD   61.56 (+1.15%)
DIS   154.14 (+0.59%)
Log in
OTCMKTS:TMPMU

Turmeric Acquisition Stock Forecast, Price & News

$10.06
+0.02 (+0.20 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$10.02
Now: $10.06▼
$10.14
50-Day Range N/A
52-Week Range
$9.95
Now: $10.06▼
$10.24
Volume14,871 shs
Average Volume24,928 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Turmeric Acquisition Corp.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.00 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry --
Sub-IndustryN/A
Sector--
Current SymbolOTCMKTS:TMPMU
Previous Symbol
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
$10.06
+0.02 (+0.20 %)
(As of 12/4/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TMPMU News and Ratings via Email

Sign-up to receive the latest news and ratings for TMPMU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Turmeric Acquisition (OTCMKTS:TMPMU) Frequently Asked Questions

What stocks does MarketBeat like better than Turmeric Acquisition?

Wall Street analysts have given Turmeric Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Turmeric Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Turmeric Acquisition's key competitors?

Some companies that are related to Turmeric Acquisition include 378 (SCCB), ACE Convergence Acquisition (ACEVU), AEA-Bridges Impact (IMPXU), Aequi Acquisition (ARBGU), AllianzGI Artificial Intelligence Opportunities Fund (AIO), Altimeter Growth (AGCUU), ArcLight Clean Transition (ACTCU), Atlas Crest Investment (ACICU), Avanti Acquisition (AVANU), Blackstone / GSO Floating Rate Enhanced Income Fund (BGFVX), Blackstone / GSO Floating Rate Enhanced Income Fund (BGFPX), Bluescape Opportunities Acquisition (BOACU), Breeze Holdings Acquisition (BREZU), Burgundy Technology Acquisition (BTAQU) and Cannara Biotech (CNBTF).
View all competitors.

What is Turmeric Acquisition's stock symbol?

Turmeric Acquisition trades on the OTCMKTS under the ticker symbol "TMPMU."

When did the company's quiet period expire?

Turmeric Acquisition's quiet period expired on Wednesday, November 25th. Turmeric Acquisition had issued 8,500,000 shares in its IPO on October 16th. The total size of the offering was $85,000,000 based on an initial share price of $10.00. During the company's quiet period, insiders and underwriters that worked on the IPO were prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Turmeric Acquisition?

Shares of TMPMU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Turmeric Acquisition's stock price today?

One share of TMPMU stock can currently be purchased for approximately $10.06.

This page was last updated on 12/4/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.